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120a Sunday, February 21, 2010rectification. A genetically encoded Eag domain fragment (amino acids 1-135)
was shown to restore slow deactivation to N-truncated channels. Our present
study sought to further investigate Eag domain contributions to hERG gating
kinetics. We coexpressed the genetically encoded Eag domain fragment (N1-
135) with hERG channels bearing a deletion of the N-terminus in Xenopus oo-
cytes and measured current with two-electrode voltage-clamp recordings. Here
we report that coexpression with the N1-135 peptide led to a reduction in rel-
ative outward current and slowed recovery from inactivation resulting in chan-
nels with properties similar to those measured in wild-type hERG. Through reg-
ulation of deactivation and inactivation gating, the Eag domain determines the
physiologically critical resurgent component of hERG current via a non-cova-
lent interaction with the channel.
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hERG channel gating is associated with relatively slow voltage sensor move-
ment that limits the rate of channel opening and closing. The mechanistic basis
underlying the constraints upon sensor movement in these channels is unclear.
Here, we have used voltage clamp fluorimetry (VCF) to study the effects of mu-
tations within the S4-S5 linker on voltage sensor movement and its coupling to
the pore. Mutations at G546 had two separable effects on activation and deac-
tivation gating. Substitution of G546 with residues possessing different phys-
ico-chemical properties all (with the exception of G546C) shifted activation
gating by ~30mV in the hyperpolarizing direction. With the activation shift
taken into account, the time constant of ionic current activation was also accel-
erated. In addition, a number of G546 mutants affected deactivation gating, al-
though the effects of different mutations varied. In the most dramatic case, the
G546V mutation induced biphasic deactivation with a pronounced slow com-
ponent that was voltage-independent. Deletion of the N-terminus accelerated
the fast component, but the slow component remained pronounced, suggesting
that the slow component was not mediated by altered interaction with the
N-terminus. VCF measurements of voltage sensor movement in G546V chan-
nels revealed fast and slow components of fluorescence change associated with
deactivation, suggesting that the slow component of ionic current deactivation
is due to slow voltage sensor return that is uncoupled from charge movement.
Taken together, these data suggest: 1) reduced flexibility of the S4-S5 linker
helix reduces constraints on voltage sensor movement during activation gating;
2) normal hERG channel closing involves at least two reconfigurations of the
voltage sensor that are rate-limiting for pore closure.
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The human ether-a-go-go-related gene 1 (hERG1) encodes a voltage-depen-
dent potassium (Kþ) channel which underlies the cardiac delayed-rectifier
Kþ current (IKr). The closing rate of the channel is a major determinant
of the amplitude of outward current, and is regulated by an N-terminal
Per-Arnt-Sim (PAS) domain. Loss of function mutations in hERG1 result
in a loss of IKr and lead to congenital Long QT Syndrome 2 (LQT2).
Only a small percentage of the PAS domain LQT2 mutations have been
characterized in mammalian cells, and these exhibited a variety of defects.
Therefore, it remains unclear as to how LQT2 mutations located in the
PAS domain disrupt hERG1 function. To address this, we have selected
12 PAS domain LQT2 mutations and, using biochemistry and electrophysi-
ology, examined their functional properties when expressed at physiological
temperatures. Our data demonstrate that channels with LQT2 mutations lo-
cated in the PAS domain exhibit a spectrum of deficiencies when cultured
at 37oC. Western blot analysis indicated that some mutations are traffick-
ing-deficient, evident by detection of only the immature form of the channel;
others were indistinguishable from WT hERG1, with enriched expression of
both the immature and mature forms; while the remaining exhibited interme-
diate levels of maturation. Whole-cell patch-clamp analysis revealed that the
LQT2 PAS domain mutants produce functional channels at the cell surface
with perturbed deactivation kinetics. Co-expression of a genetically-encoded
N-terminal peptide with these gating-deficient mutants rescued the gating-
deficiency and fully restored the WT phenotype. Taken together, these
data are the first to characterize purely gating-deficient hERG1 PAS domain
LQT2 mutations expressed in mammalian cells, and show that a genetically-encoded N-terminal peptide is able to fully restore the WT phenotype to the
channels.
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Block of the cardiac potassium channel HERG by a number of drugs has
been shown to decrease with an increase in the extracellular potassium con-
centration. This dependency on extracellular potassium can be explained by
at least two mechanisms: 1) destabilization of the drug by the permeant ion
2) differential binding to the inactivated state. We have previously shown
that block of HERG by quinidine, a drug that is not trapped after channel de-
activation, correlates better with the permeant ion than with inactivation, in-
dicating that quinidine block is destabilized by the permeant ion.1 We show
here that block of HERG by terfenadine and bepridil, drugs shown to be trap-
ped in the channel after channel deactivation2, is not altered with an increase
in the extracellular potassium concentration. Furthermore block by both ter-
fenadine and bepridil of the HERG mutant D540K, which opens with both
depolarization and hyperpolarization, is decreased with increased extracellu-
lar potassium, similar to the effect of extracellular potassium on block of WT
HERG by quinidine. In addition, the decrease in block of D540K by bepridil
is less with an increase in extracellular cesium compared to an increase in
extracellular potassium (PCs/PK ¼ 0.33). Finally, preliminary data indicate
that block by bepridil of a number of HERG inactivation deficient mutants
does not depend on extracellular potassium. Together these results suggest
that the permeant ion is not able to destabilize a trapped drug but is able
to destabilize a drug that is not trapped and suggest a possible role for the
activation gate in determining the extracellular potassium dependency of
block of HERG.
1Barrows et al. (2009) Channels: 3(4) :239-248.
2 Stork et al. (2007) BJP151:1368-1376.
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Malfunction of hERG Kþ channels, due to inherited mutations or inhibition
by drugs can cause long QT syndrome, which may lead to life-threatening ar-
rhythmias. A 3-dimensional hERG structure is a prerequisite to understand the
molecular basis of hERG malfunction. To achieve a consensus model we have
carried out an extensive analysis of hERG models, based on different align-
ments of helix S5. The consensus model was validated using a combination
of geometry/packing/normality validation, as well as molecular dynamics sim-
ulations and molecular docking. The model is confirmed by a recent mutation
scanning experiment.1 Subsequently, the refined model was used to study the
conformational flexibility of the hERG pore domain. Extensive molecular dy-
namics simulations revealed that the aromatic side-chains, lining the inner
cavity can adopt a wide variety of conformations. Detailed knowledge of
the hERG channel plasticity will be crucial to help interpreting differences
in channel block of different drugs, since many drugs selectively block certain
channel states.
1 Ju, P., Pages, G., Riek, R. P., Chen, P.C., Torres, A. M., Bansal, P. S.,
Kuyucak, S., Kuchel P. W, Vandenberg, J.I. (2009) J. Biol. Chem. 284,
1000-1008.
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KCNQ1 a-subunits are composed out of six transmembrane segments (S1-S6)
that tetramerize into a functional channel. In vivo, KCNQ1 a-subunits associ-
ate with the b-subunit KCNE1 to generate the slowly activating cardiac IKs
and consequently mutations in KCNQ1 are linked to the congenital LQT1
syndrome. Similar to other Kv channels, the S1-S4 segments form the voltage
sensing domain that senses the membrane potential and that controls the
